Sign Up for a Free Account
  • Updated 10.15.2021
  • Released 06.30.1999
  • Expires For CME 10.15.2024



Historical note and terminology

Tizanidine is a centrally acting alpha2-adrenergic agonist that was approved as an antispastic drug by the United States Food and Drug Administration in 1996.

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660



ISSN: 2831-9125